Churg-Strauss syndrome: A case report

  • Miroslav Ž. Dinić, Department of Dermatovenerology, Military Medical Academy, Belgrade, Serbia
  • Lidija Kandolf Sekulović Department of Dermatovenerology, Military Medical Academy, Belgrade, Serbia;
  • Lidija Zolotarevski Center of Pathology and Forensic Medicine, Military Medical Academy, Belgrade, Serbia
  • Radoš D. Zečević Department of Dermatovenerology, Military Medical Academy, Belgrade, Serbia

Abstract


Introduction. Churg-Strauss syndrome (CSS) is an allergic granulomatous angiitis, a rare disease of small and medium arteries and veins, associated with the presence of perinuclear antineutrophil cytoplasmic antibodies (p-ANCA). According to the American College of Rheumatology (ACR), there are four or more criteria out of six for the diagnosis: asthma, eosinophilia (> 10% in peripheral blood), paranasal sinusitis, pulmonary infiltrates, histological evidence of vasculitis with extravascular eosinophils, and mononeuritis multiplex or polyneuropathy. Case report. We reported a female patient, aged 80 years, with asthma for many decades and repeatedly verified eosinophilia in peripheral blood, in which CSS was suspected only after the occurrence of skin changes in the form of vesicles, vesiculopustule, purpuric macula, papule and petechiae. Further tests verified pulmonary infiltrates, paranasal sinusitis, extravascular eosinophils on histopathologic sample of skin tissue, and polyneuropathy. The treatment started with methylprednisolone (60 mg/d, with decreasing doses), and continued with pulse doses of cyclophosphamide (800 mg once monthly), also corticosteroid ointment for skin lesions. Conclusion. Despite long-standing pulmonary symptoms and laboratory findings of eosinophilia, the appearance of skin changes raised suspicion of possible CSS. Skin changes resolved and the patient was reffered to rheumatologist.

 

Key words:

churg-strauss syndrome; diagnosis; skin diseases; histological techniques.

References

Marzano AV, Vezzoli P, Berti E. Skin involvement in cutaneous and systemic vasculitis. Autoimmun Rev 2013; 12(4): 467−76.

Cox NH, Jorizzo JL, Bourke JF, Savage CO. Vasculitis neutrophilic dermatoses and related disorders. In: Burns I, Breathnach S, Cox N, Griffiths CC, editors. Rook's textbook of dermatology. Oxford: Wiley-Blackwell; 2010. p. 2360−454.

Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998; 7(4): 238−58.

Gota CE, Mandell BF. Systemic necrotizing vasculitis. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's Dermatology in General Medicine. New York: McGraw Hill; 2008. p. 1606−16.

Hellmich B, Ehlers S, Csernok E, Gross WL. Update on the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol 2003; 21(6 Suppl 32): 69−7.

Grau RG. Churg-Strauss syndrome: 2005-2008 update. Curr Rheumatol Rep 2008; 10(6): 453−8.

Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33(8): 1094−100.

Phillip R, Lugmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008; 26(5 Suppl 51): S94−104.

Chung L, Kea B, Fiorentino DF. Cutaneous vasculitis. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. Philadelphia: Mosby Elsevier; 2008. p. 361−2.

Published
2017/01/19
Section
Case report